Published in Antimicrob Agents Chemother on July 01, 1986
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. Antimicrob Agents Chemother (1988) 1.61
Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay. Antimicrob Agents Chemother (1991) 1.37
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. Antimicrob Agents Chemother (1992) 1.29
Effect of roxithromycin on acute toxoplasmosis in mice. Antimicrob Agents Chemother (1987) 1.28
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob Agents Chemother (1988) 0.99
In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages. Antimicrob Agents Chemother (1989) 0.97
Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitro. Antimicrob Agents Chemother (1991) 0.80
Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin. Antimicrob Agents Chemother (2002) 0.80
Quinine uptake by human polymorphonuclear neutrophils. Antimicrob Agents Chemother (1991) 0.76
Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06
Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol (1975) 6.19
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61
In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. Antimicrob Agents Chemother (1983) 3.70
Quantitative leukocyte iodination. N Engl J Med (1971) 3.46
In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1984) 3.45
The role of oxygen and its derivatives in microbial pathogenesis and host defense. Annu Rev Microbiol (1984) 2.52
Effect of antibiotics of chemotaxis of human leukocytes. Antimicrob Agents Chemother (1977) 2.04
Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system. J Clin Invest (1982) 2.04
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes. Antimicrob Agents Chemother (1976) 1.97
Interactions of antibiotics and phagocytes. J Antimicrob Chemother (1983) 1.69
A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitro. J Immunol Methods (1977) 1.57
Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin. Antimicrob Agents Chemother (1985) 1.56
The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol (1978) 1.56
A radiometric assay for the combined measurement of phagocytosis and intracellular killing of Candida albicans. Clin Exp Immunol (1980) 1.46
In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1979) 1.46
Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila. J Infect Dis (1984) 1.34
Kinetics of phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes. Scand J Immunol (1981) 1.27
Oxygen consumption during the initial stage of human leucocyte phagocytosis of polystyrene latex particles. Scand J Clin Lab Invest (1970) 1.10
Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte. Rev Infect Dis (1982) 1.06
Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone. Biochem Pharmacol (1982) 1.02
Influence of bacterial-antibiotic interactions on subsequent antimicrobial activity of alveolar macrophages. J Infect Dis (1984) 0.98
[RU 28965, a new semi-synthetic macrolide. Bioavailability and pharmacokinetic profile after oral administration]. Pathol Biol (Paris) (1985) 0.97
Quantitative iodination of human blood polymorphonuclear leukocytes. Eur J Clin Invest (1975) 0.96
Further studies on erythromycin effects on cellular immune functions in vitro and in vivo. Enhancement of neutrophil motility by erythromycin combined with ascorbate or thiamine. J Antimicrob Chemother (1982) 0.94
Metabolic activity of human polymorphonuclear leucocytes: relation to ingestion rate. Eur J Clin Invest (1979) 0.93
Antibiotics and host defence with special reference to phagocytosis by human polymorphonuclear leukocytes. J Antimicrob Chemother (1985) 0.92
Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics. J Antimicrob Chemother (1984) 0.90
Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes. J Antimicrob Chemother (1984) 0.90
Differences in phagocytic/adherence properties between normal neutrophils. Scand J Haematol (1984) 0.85
In-vivo effects of clindamycin on neutrophil function--a preliminary report. J Antimicrob Chemother (1983) 0.81
[Subinhibitory concentrations of antibiotics. Effects on morphology and growth (author's transl)]. Pathol Biol (Paris) (1977) 0.81
Inhibition of PMN leukocytes chemotaxis by thalidomide. Arch Dermatol Res (1980) 0.79
Differential stimulation of lymphocyte cell growth in vitro by cephalosporins. Antimicrob Agents Chemother (1984) 0.78
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res (1993) 2.05
Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood (1997) 1.64
Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol (2001) 1.64
Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob Agents Chemother (1997) 1.52
A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5. Clin Exp Immunol (1978) 1.49
Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob Agents Chemother (1998) 1.42
Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides. Antimicrob Agents Chemother (1995) 1.19
Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood (1998) 1.19
p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg (1994) 1.15
Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J Biol Chem (1997) 1.15
Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J Antimicrob Chemother (1994) 1.15
Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun (1994) 1.13
Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation. Thromb Haemost (1993) 1.13
Blindness associated with midfacial fractures. J Oral Maxillofac Surg (1998) 1.10
Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood (1994) 1.10
Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis (2012) 1.08
Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. J Antimicrob Chemother (1989) 1.03
Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone. Biochem Pharmacol (1982) 1.02
Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis. Eur J Clin Invest (1977) 1.01
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob Agents Chemother (1988) 0.99
Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load. J Virol (1999) 0.97
Quantitative iodination of human blood polymorphonuclear leukocytes. Eur J Clin Invest (1975) 0.96
Metabolic activity of human polymorphonuclear leucocytes: relation to ingestion rate. Eur J Clin Invest (1979) 0.93
P40phox associates with the neutrophil Triton X-100-insoluble cytoskeletal fraction and PMA-activated membrane skeleton: a comparative study with P67phox and P47phox. J Leukoc Biol (1999) 0.93
The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe. Trop Med Int Health (2012) 0.91
[A new erythroenzymopathy: congenital non-spherocytic hemolytic anemia and hereditary erythrocytic adenylate kinase deficiency]. Presse Med (1971) 0.91
Metabolic activity of phagocytosing granulocytes in chronic granulocytic leukemia: ultrastructural observation of a degranulation defect. Blood (1977) 0.91
Interleukin-8 production by polymorphonuclear neutrophils in patients with rapidly progressive periodontitis: an amplifying loop of polymorphonuclear neutrophil activation. Lab Invest (1998) 0.91
Staurosporine, a protein kinase inhibitor, up-regulates the stimulation of human neutrophil respiratory burst by N-formyl peptides and platelet activating factor. Biochem Biophys Res Commun (1990) 0.91
Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils. Antimicrob Agents Chemother (2000) 0.90
Mechanism underlying levofloxacin uptake by human polymorphonuclear neutrophils. Antimicrob Agents Chemother (1999) 0.90
The role of phagocytes in HIV-related oxidative stress. J Clin Virol (2001) 0.90
Stimulation of the human neutrophil respiratory burst by formyl peptides is primed by a protein kinase inhibitor, staurosporine. Blood (1993) 0.90
Immunochemical identification and translocation of protein kinase C zeta in human neutrophils. FEBS Lett (1994) 0.89
Chemoattractant and opsonic activity in ascitic fluid. A study in 47 patients with cirrhosis or malignant peritonitis. J Hepatol (1991) 0.88
Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler Thromb Vasc Biol (1997) 0.88
Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity. J Antimicrob Chemother (1987) 0.88
Protection of rat from oxygen toxicity by inducers of cytochrome P-450 system. Am Rev Respir Dis (1988) 0.88
Involvement of hydroxyl radical in NAD(P)H oxidation and associated oxygen reduction by the granule fraction of human blood polymorphonuclears. Biochem Biophys Res Commun (1978) 0.86
Effects of dirithromycin and erythromycylamine on human neutrophil degranulation. Antimicrob Agents Chemother (1994) 0.86
Superoxide anion production by liver microsomes from phenobarbital treated rat. Biochem Pharmacol (1978) 0.86
Isolation, culture and characterization of adult human hepatocytes from surgical liver biopsies. Hepatology (1984) 0.86
Interaction of rifalazil with oxidant-generating systems of human polymorphonuclear neutrophils. Antimicrob Agents Chemother (2005) 0.85
[Macrolides. New therapeutic prospects]. Presse Med (1994) 0.85
An evaluation of a clerkship in cardiology for general practitioners. J Med Educ (1969) 0.85
Gd(minus)Matam, an African glucose-6-phosphate dehydrogenase variant with enzyme deficiency. Biochemical and immunological properties in various hemopoietic tissues. Clin Chim Acta (1975) 0.84
Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells. Arthritis Rheum (1997) 0.84
Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Arterioscler Thromb Vasc Biol (2000) 0.83
Diclofenac sodium, a negative chemokinetic factor for neutrophil locomotion. Biochem Pharmacol (1985) 0.83
Studies on the mechanism of NADPH oxidation by the granule fraction isolated from human resting polymorphonuclear blood cells. Biochimie (1976) 0.83
Bilirubin and paranitrophenol glucuronyl transferase activities and ultrastructural aspect of the liver in patients with chronic hemolytic anemias. Biomedicine (1976) 0.83
Defective priming of the phagocyte oxidative burst in a child with recurrent intracellular infections. Microbes Infect (1999) 0.83
Antibodies to proteinase-3 mediate expression of intercellular adhesion molecule-1 (ICAM-1, CD 54). Br J Rheumatol (1997) 0.82
Interleukin 4 prevents the induction of tissue factor mRNA in human monocytes in response to LPS or PMA stimulation. Br J Haematol (1993) 0.82
Comparison of blocking effects of monoclonal antibodies anti-MO1-alpha and anti-LFA1-alpha on human neutrophil functions. Immunology (1987) 0.82
Interleukin-10 and pentoxifylline inhibit C-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes. FEBS Lett (1994) 0.82
Priming of phosphatidic acid production by staurosporine in f-Met-Leu-Phe-stimulated human neutrophils--correlation with respiratory burst. Cell Signal (1998) 0.82
Comparative sugar degradation by (OH). produced by the iron-driven Fenton reaction and gamma radiolysis. Arch Biochem Biophys (1994) 0.81
Syndrome of inappropriate secretion of antidiuretic hormone: association with cavernous sinus thrombosis. JAMA (1978) 0.81
In vivo effects of indomethacin and flurbiprofen on the locomotion of neutrophils elicited by immune and non-immune inflammation in the rat. Eur J Pharmacol (1984) 0.81
Effects of cefotaxime and cefodizime on human granulocyte functions in vitro. J Antimicrob Chemother (1986) 0.81
[Importance and role of imidazole and sulfhydryl groups in the catalytic activity of human erythrocyte glucose-6-phosphate dehydrogenase]. Biochimie (1972) 0.80
A protein kinase inhibitor, staurosporine, enhances the expression of phorbol dibutyrate binding sites in human polymorphonuclear leucocytes. Biochem J (1993) 0.80
Diclofenac binding to human polymorphonuclear neutrophils: effect on respiratory burst and N-formylated peptide binding. Biochem Pharmacol (1987) 0.80
Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood. Eur Cytokine Netw (1998) 0.80
Impaired metabolic activity of phagocytosing neutrophils in agnogenic osteomyelofibrosis with splenomegaly: a longitudinal study. Am J Hematol (1984) 0.80
Isolation and characterization of rat intestinal polyribosomes and RNA during absorption of fat. Increased translation in vitro of apo-AIV. Biochem Biophys Res Commun (1985) 0.80
Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes. Thromb Haemost (1995) 0.80
Acquired erythroenzymopathies in blood disorders: study of 200 cases. Br J Haematol (1975) 0.80
Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin. Antimicrob Agents Chemother (2002) 0.80
Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI. Arterioscler Thromb Vasc Biol (1999) 0.80
[Congenital deficiency erythrocyte adenylate-kinase]. Presse Med (1970) 0.80
W-7, a calmodulin antagonist, primes the stimulation of human neutrophil respiratory burst by formyl peptides and platelet-activating factor. FEBS Lett (1994) 0.80
Inhibition of human neutrophil protein kinase C activity by the antimalarial drug mefloquine. Biochem Pharmacol (1992) 0.80
Superoxide anion involvement in NBT reduction catalyzed by NADPH-cytochrome P-450 reductase: a pitfall. FEBS Lett (1978) 0.79
Cyanide-insensitive NADH oxidation by subcellular fractions isolated from human polymorphonuclear blood cells. Enzyme (1978) 0.79
Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophils. Eur J Pharmacol (1995) 0.79
Effect of quinine and cinchonine on human neutrophils functions in vitro. J Antimicrob Chemother (1990) 0.79
[Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo]. Pathol Biol (Paris) (1988) 0.79
Images in cardiovascular medicine: ruptured aneurysm of the sinus of Valsava. Cent Afr J Med (1999) 0.79
Interaction of macrolides and ketolides with the phagocytic cell line PLB-985. J Chemother (2003) 0.79
NADPH-oxidation activities in subcellular fractions isolated from resting or phagocytozing human polymorphonuclears. Am J Hematol (1978) 0.79